These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 3061265)
21. Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development. Cryz SJ; Mortimer PM; Mansfield V; Germanier R J Clin Microbiol; 1986 Apr; 23(4):687-90. PubMed ID: 3517058 [TBL] [Abstract][Full Text] [Related]
22. Identification and Evaluation of Recombinant Outer Membrane Proteins as Vaccine Candidates Against Zhang BZ; Hu D; Dou Y; Xiong L; Wang X; Hu J; Xing SZ; Li W; Cai JP; Jin M; Zhang M; Lin Q; Li M; Yuen KY; Huang JD Front Immunol; 2021; 12():730116. PubMed ID: 34745099 [No Abstract] [Full Text] [Related]
23. Early cytokine response to lethal challenge of Klebsiella pneumoniae averted the prognosis of pneumonia in FyuA immunized mice. Kumar A; Harjai K; Chhibber S Microb Pathog; 2020 Jul; 144():104161. PubMed ID: 32194179 [TBL] [Abstract][Full Text] [Related]
26. Protection against fatal Klebsiella pneumoniae sepsis in the squirrel monkey Saimiri sciureus after immunization with a capsular polysaccharide vaccine. Postal JM; Gysin J; Crenn Y Ann Inst Pasteur Immunol; 1988; 139(4):401-7. PubMed ID: 3048318 [TBL] [Abstract][Full Text] [Related]
27. Development of immunization trials against Klebsiella pneumoniae. Ahmad TA; El-Sayed LH; Haroun M; Hussein AA; El Ashry el SH Vaccine; 2012 Mar; 30(14):2411-20. PubMed ID: 22100884 [TBL] [Abstract][Full Text] [Related]
29. [Capsular polysaccharide of Klebsiella pneumoniae. II. Immunogenic properties]. Alcántar-Curiel MD; Martínez-Ramos A; García-Latorre E Rev Latinoam Microbiol; 1993; 35(1):109-15. PubMed ID: 8140330 [TBL] [Abstract][Full Text] [Related]
30. Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans. Cryz SJ; Fürer E; Germanier R J Infect Dis; 1985 Apr; 151(4):665-71. PubMed ID: 3882856 [TBL] [Abstract][Full Text] [Related]
31. Potential of Klebsiella pneumoniae cytotoxin toxoid as vaccine against klebsiellosis in rabbits and mice. Singh BR; Sharma VD Vaccine; 2001 Aug; 19(31):4505-10. PubMed ID: 11483277 [TBL] [Abstract][Full Text] [Related]
32. Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa. Hegerle N; Choi M; Sinclair J; Amin MN; Ollivault-Shiflett M; Curtis B; Laufer RS; Shridhar S; Brammer J; Toapanta FR; Holder IA; Pasetti MF; Lees A; Tennant SM; Cross AS; Simon R PLoS One; 2018; 13(9):e0203143. PubMed ID: 30188914 [TBL] [Abstract][Full Text] [Related]
33. [The reactogenicity and immunological efficacy of a Klebsiella vaccine in donors]. Kurbatova EA; Egorova NB; Dubova VG; Davatdarova GM; Lipats AA; Gervazieva VB; Kaverina KG Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):53-6. PubMed ID: 2201154 [TBL] [Abstract][Full Text] [Related]
34. Dose-dependent efficacy of vaccination against K. pneumoniae in high and low antibody responder lines of mice. Mouton D; Parant M; Mevel JC; Parant F Immunol Lett; 1987 Apr; 14(4):335-9. PubMed ID: 3294582 [TBL] [Abstract][Full Text] [Related]
35. Results of passive and active immunization directed against ferric aerobactin in experimental enterobacterial infections in mice and chickens. Le Roy D; Crouzier C; Dho-Moulin M; Dumont AS; Bouchet A; Lafont JP; Andremont A Res Microbiol; 1995 Feb; 146(2):167-74. PubMed ID: 7652210 [TBL] [Abstract][Full Text] [Related]
36. Oral administration of Lactobacillus plantarum expressing aCD11c modulates cellular immunity alleviating inflammatory injury due to Klebsiella pneumoniae infection. Zeng Y; Li T; Chen X; Fang X; Fang C; Liang X; Liu J; Yang Y BMC Vet Res; 2024 Sep; 20(1):399. PubMed ID: 39244529 [TBL] [Abstract][Full Text] [Related]
37. [The intensity and dynamics of the development of immunity in the administration of experimental corpuscular ozena vaccines]. Molochko VA; Krasil'nikov AP; Krylov IA; Lastochkina TM Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):49-52. PubMed ID: 3414235 [TBL] [Abstract][Full Text] [Related]
38. Study of the mode of action of ribosomal vaccines from Klebsiella and Streptococcus pneumoniae and their ribonucleic and protein fractions using passive immunization. Robert D; Ivanoff B; Fontanges R; Normier G; Pinel AM; Dussourd D'Hinterland L Microbiol Immunol; 1982; 26(10):933-40. PubMed ID: 6186896 [TBL] [Abstract][Full Text] [Related]
39. Klebsiella pneumoniae type 3 fimbria-mediated immunity to infection in the murine model of respiratory disease. Lavender H; Jagnow JJ; Clegg S Int J Med Microbiol; 2005 Jun; 295(3):153-9. PubMed ID: 16047414 [TBL] [Abstract][Full Text] [Related]
40. Immunoprotective potential of polysaccharide-tetanus toxoid conjugate in Klebsiella pneumoniae induced lobar pneumonia in rats. Chhibber S; Rani M; Vanashree Y Indian J Exp Biol; 2005 Jan; 43(1):40-5. PubMed ID: 15691064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]